HSA — authorised 22 October 2012
- Marketing authorisation holder: EISAI INC
- Status: likely_approved
HSA authorised Fycompa on 22 October 2012
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 22 October 2012.
EISAI INC holds the Singaporean marketing authorisation.